Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
language:"Italian"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=language%3A%22Italian%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=language%3A%22Italian%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=language%3A%22Italian%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (58)
1
Studio per valutare la sicurezza e l'efficacia del selinexor vs. trattamento di scelta del medico in pazienti con mielofibrosi già precedentemente trattata. : A phase 2, randomized, open-label, multicenter study to evaluate safety and efficacy of single agent selinexor versus treatment of physician's choice in patients with previously treated myelofibrosis - XPORT-MF-035
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
Studio per valutare la sicurezza e l'efficacia del selinexor vs. trattamento di scelta del medico in pazienti con mielofibrosi già precedentemente trattata. : A phase 2, randomized, open-label, multicenter study to evaluate safety and efficacy of single agent selinexor versus treatment of physician's choice in patients with previously treated myelofibrosis - XPORT-MF-035
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
Nuovi end-points clinici in pazienti con sindrome di Sjögren primaria (pSS): uno studio interventistico basato sulla stratificazione dei pazienti. : NEw Clinical End-points in patients with primary Sjögren's Syndrome (pSS): an Interventional Trial based on stratifYing patients - NECESSITY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Nuovi end-points clinici in pazienti con sindrome di Sjögren primaria (pSS): uno studio interventistico basato sulla stratificazione dei pazienti. : NEw Clinical End-points in patients with primary Sjögren's Syndrome (pSS): an Interventional Trial based on stratifYing patients - NECESSITY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Terapia di disassuefazione con metilprednisolone e diazepam ev in pazienti affetti da cefalea cronica con uso eccessivo di sintomatici : Terapia di disassuefazione con metilprednisolone e diazepam ev in pazienti affetti da cefalea cronica con uso eccessivo di sintomatici - WASH-OUT
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
6
Terapia di disassuefazione con metilprednisolone e diazepam ev in pazienti affetti da cefalea cronica con uso eccessivo di sintomatici : Terapia di disassuefazione con metilprednisolone e diazepam ev in pazienti affetti da cefalea cronica con uso eccessivo di sintomatici - WASH-OUT
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
7
Studio per verificare efficacia, sicurezza e tollerabilità di bepranemab (UCB0107) in pazienti con deterioramento cognitivo o Malattia di Alzheimer (AD) lieve : A PATIENT- AND INVESTIGATOR-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BEPRANEMAB (UCB0107) IN STUDY PARTICIPANTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE (AD), FOLLOWED BY AN OPEN-LABEL EXTENSION PERIOD - NA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
Studio per verificare efficacia, sicurezza e tollerabilità di bepranemab (UCB0107) in pazienti con deterioramento cognitivo o Malattia di Alzheimer (AD) lieve : A PATIENT- AND INVESTIGATOR-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BEPRANEMAB (UCB0107) IN STUDY PARTICIPANTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE (AD), FOLLOWED BY AN OPEN-LABEL EXTENSION PERIOD - NA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
Uno studio di fase 3b/4 sull'Artrite Reumatoide : A Randomized, Active Controlled, Parallel Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis. - RA-BRIDGE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
Studio con JDQ443 in pazienti con tumori solidi in stadio avanzato con mutazione KRAS G12C : A phase Ib/II open-label, multi-center dose escalation study of JDQ443 in patients with advanced solid tumors harboring the KRAS G12C mutation - -
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
3
4
5
6
Nächster »
[6]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Sprache: Italienisch
Medienart
58
Aufsätze
58
E-Artikel
58
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
58
610
58
Recruitment Status: Authorised-recruitment may ...
58
Study Type: Interventional
14
Phase: Phase 2
10
Phase: Phase 3
4
Phase: Phase 1
2
Medical Condition: Alzheimer's Disease MedDRA v...
2
Medical Condition: Breast cancer - Stage 1-2 to...
2
Medical Condition: Children with medulloblastom...
2
Medical Condition: Distrofia Muscolare di Duche...
2
Medical Condition: Early-stage (I [> 2 cm] to I...
2
Medical Condition: Emicrania Cronica e Cefalea ...
2
Medical Condition: Heart Failure with preserved...
2
Medical Condition: Heart transplant MedDRA vers...
2
Medical Condition: Leucemia Linfoblastica Acuta...
2
Medical Condition: Localization-related, genera...
2
Medical Condition: Locally advanced or metastat...
2
Medical Condition: MALATTIA DI Alzheimer MedDRA...
2
Medical Condition: Menopausa fisiologica MedDRA...
2
Medical Condition: Myelofibrosis MedDRA version...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
22
2020-
36
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Italienisch
Haven't found what you're looking for?
Wird geladen...